Techno Medica Co., Ltd. logo

Techno Medica Co., Ltd.

6678.T

JPXHealthcareMedical - Devices

Latest quote

¥2,125

+¥3.00 · +0.14%

Aug 24, 3:30 PM JST

6678.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Techno Medica Co., Ltd. is a Japanese company that specializes in the entire lifecycle of in-vitro diagnostic analyzers, covering their research, development, manufacturing, distribution, and international trade. Their product portfolio includes automated systems for test tube preparation, urine aliquot, and RFID-based management solutions for both biological specimens and blood transfusions. The company also supplies a diverse range of analytical instruments for measuring blood gases, electrolytes, erythrocyte sedimentation rates, nutrient levels, sugar and acid content, and for performing urine chemistry tests. Furthermore, Techno Medica provides electronic medical charting systems, various pre-analytical devices, essential consumables, and comprehensive after-sales support. Established in 1987, the company's main office is located in Yokohama, Japan.

Industry
Medical - Devices
Sector
Healthcare
Headquarters
JP
CEO
Masatomo Saneyoshi
Listed since
Mar 12, 2007
Employees
239

Market position

Day range

Current ¥2,125

52-week range

Current ¥2,125

Open
¥2,129
Previous close
¥2,122
Volume
4.2K
0.32× average
Average volume
13.28K
Average daily volume
Market cap
14.17B JPY
Beta
0.24
Market reference 1
50-day average
¥2,033.06
+4.52% above average
200-day average
¥2,183.48
-2.68% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
7.16B JPY
P/E (TTM)
12.02×
P/B (TTM)
1.03×
P/S (TTM)
1.21×
EV / EBITDA
4.06×
Earnings yield
6.64%
Free cash flow yield
6.61%
Dividend yield
6.07%

Profitability & efficiency

Gross margin
46.91%
Operating margin
16.33%
Net margin
10.39%
Return on equity
7.43%
Return on assets
5.96%
Return on invested capital
7.87%

Financial health

Debt / equity
Current ratio
5.09×

Earnings

Latest fiscal-year EPS
155.28
FY2025 · +7.03% year over year
Latest fiscal-year revenue
11.24B JPY
FY2025 · +13.43% year over year

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend176.61161.97147.33132.69FY21FY22FY23FY24FY25

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend11.42B10.68B9.93B9.18BFY21FY22FY23FY24FY25

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥68.00

2025 complete year+38.8% since 2021

2026 partial: ¥129

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Mar 30, 2027

¥93.00

Annual

Record Mar 31, 2027 · Payment Mar 30, 2027

Dividend

Ex-dividend Mar 30, 2026

¥129

Annual

Record Mar 31, 2026 · Payment Jun 26, 2026

Dividend

Ex-dividend Mar 28, 2025

¥68.00

Annual

Record Mar 31, 2025 · Payment Jun 27, 2025

Dividend

Ex-dividend Mar 28, 2024

¥68.00

Annual

Record Mar 31, 2024 · Payment Jun 27, 2024

Dividend

Ex-dividend Mar 30, 2023

¥60.00

Annual

Record Mar 31, 2023 · Payment Jun 29, 2023

Dividend

Ex-dividend Mar 30, 2022

¥60.00

Annual

Record Mar 31, 2022 · Payment Jun 29, 2022

6678.T peers

ETFs holding 6678.T

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 6678.T

research.disclaimer